BioMedSA’s Board of Directors approved 3 new memberships in February 2024: Denovo Innovations Group, Hogan Lovells, J.R. Stockton Consulting, and LCM Biosensor Technologies.
Denovo Innovations Group works to transform modern healthcare through data science, data analytics and software solutions with a focus on collaborating and supporting early-stage startups that seek commercialization. Data solutions expertise ranges from team building, ideation, and validation to fractional leadership for digital health, therapeutic, and wellness spaces.
Hogan Lovells addresses legal challenges that face the healthcare and bioscience industry by focusing on specific needs regardless of company size – startups to global enterprises. Areas of focus include: med device, biotechnology, emerging companies, clinical trials, digital health, cell/tissue/gene therapies, and licensing.
JR Stockton is an independent mechanical designer that specializes in Design for Manufacturing, including: product design and development (concept-to-completion), manufacture & scalability, design rescue, and economical production.
LCM Biosensor Technologies seeks to use non-invasive technology to determine blood glucose levels. The technology uses the relationship of intercellular osmotic pressure in the epidermis and glucose concentration and a pressure transducer to make the glucose measurement.
